Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953

Recombinant Human SF3B2 293 Cell Lysate

Cat.No. : SF3B2-1917HCL
  • Specification
  • Gene Information
  • Related Products
Description : Antigen standard for splicing factor 3b, subunit 2, 145kDa (SF3B2) is a lysate prepared from HEK293T cells transiently transfected with a TrueORF gene-carrying pCMV plasmid and then lysed in RIPA Buffer. Protein concentration was determined using a colorimetric assay. The antigen control carries a C-terminal Myc/DDK tag for detection.
Source : HEK 293 cells
Species : Human
Components : This product includes 3 vials: 1 vial of gene-specific cell lysate, 1 vial of control vector cell lysate, and 1 vial of loading buffer. Each lysate vial contains 0.1 mg lysate in 0.1 ml (1 mg/ml) of RIPA Buffer (50 mM Tris-HCl pH7.5, 250 mM NaCl, 5 mM EDTA, 50 mM NaF, 1% NP40). The loading buffer vial contains 0.5 ml 2X SDS Loading Buffer (125 mM Tris-Cl, pH6.8, 10% glycerol, 4% SDS, 0.002% Bromophenol blue, 5% beta-mercaptoethanol).
Size : 0.1 mg
Storage Instruction : Store at -80°C. Minimize freeze-thaw cycles. After addition of 2X SDS Loading Buffer, the lysates can be stored at -20°C. Product is guaranteed 6 months from the date of shipment.
Applications : ELISA, WB, IP. WB: Mix equal volume of lysates with 2X SDS Loading Buffer. Boil the mixture for 10 min before loading (for membrane protein lysates, incubate the mixture at room temperature for 30 min). Load 5 ug lysate per lane.
Gene Name : SF3B2 splicing factor 3b, subunit 2, 145kDa [ Homo sapiens ]
Official Symbol : SF3B2
Synonyms : SF3B2; splicing factor 3b, subunit 2, 145kDa; splicing factor 3b, subunit 2, 145kD; splicing factor 3B subunit 2; Cus1; SAP145; SF3b1; SF3b145; SAP 145; spliceosome associated protein 145; spliceosome-associated protein 145; pre-mRNA splicing factor SF3b 145 kDa subunit; pre-mRNA-splicing factor SF3b 145 kDa subunit; SF3B145; SF3b150;
Gene ID : 10992
mRNA Refseq : NM_006842
Protein Refseq : NP_006833
MIM : 605591
UniProt ID : Q13435
Chromosome Location : 11q13
Pathway : Gene Expression, organism-specific biosystem; Processing of Capped Intron-Containing Pre-mRNA, organism-specific biosystem; Spliceosome, organism-specific biosystem; Spliceosome, conserved biosystem; Spliceosome, U2-snRNP, organism-specific biosystem; mRNA Splicing, organism-specific biosystem; mRNA Splicing - Major Pathway, organism-specific biosystem;
Function : nucleic acid binding;

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

  • Q&As
  • Reviews

Q&As (6)

Ask a question
What are the mutation types of SF3B2? 12/17/2022

The mutation types of SF3B2 include point mutations, insertions, and deletions. Some of these mutations may cause dysfunction of the spliceosome, while others may affect its interaction with other proteins.

How to detect if there is a mutation in SF3B2? 12/12/2022

SF3B2 can be detected for mutations by gene sequencing technology. This can help doctors diagnose whether a patient has a condition related to SF3B2 and provide them with a more precise treatment plan.

How can bioinformatics methods analyze the effect of SF3B2 mutations on spliceosomes? 11/24/2022

The effect of SF3B2 mutations on spliceosomes can be analyzed by bioinformatics methods. This can predict its potential effect on the spliceosome by comparing the structure and sequence of mutant and wild-type proteins.

What are the treatment strategies for SF3B2? 04/12/2022

Therapeutic strategies for SF3B2 include inhibiting its expression, modulating its activity, or using gene therapy, among other things. For example, some studies have shown that small molecule inhibitors targeting SF3B2 can inhibit its activity and thus treat some SF3B2-related diseases. In addition, it is also possible to treat related diseases by regulating the expression level of SF3B2.

Who is at high risk of SF3B2 mutations? 10/26/2021

People with cancers such as medulloblastoma, Wilms tumor, and rhabdomyosarcoma are at high risk of SF3B2 mutations. Genetic testing of these patients can help doctors diagnose the condition more accurately and develop treatment accordingly.

What is the relationship between SF3B2 and the occurrence of the disease? 03/12/2020

Studies have shown that mutations in the SF3B2 gene are associated with the occurrence of a variety of cancers, such as medulloblastoma, Wilms tumor, rhabdomyosarcoma, etc. These mutations may cause abnormal function of the spliceosome, which in turn affects the normal growth and differentiation of cells.

Customer Reviews (3)

Write a review
Reviews
10/08/2023

    It has good crystallization properties and is suitable for analysis by X-ray crystallography.

    12/29/2021

      The SF3B2 is easy to store and has no problems with long-term storage.

      10/30/2020

        In special environments, biological activity and structural integrity can be guaranteed.

        Ask a Question for All SF3B2 Products

        Required fields are marked with *

        My Review for All SF3B2 Products

        Required fields are marked with *

        0

        Inquiry Basket

        cartIcon
        logo

        FOLLOW US

        Terms and Conditions        Privacy Policy

        Copyright © 2024 Creative BioMart. All Rights Reserved.

        Contact Us

        • /

        Stay Updated on the Latest Bioscience Trends